Evidence map›Paper›PMID 22818956›Full record

ReviewCurrent opinion in cell biology2012

Endocytosis and control of Notch signaling.

Vasundhara Kandachar, Fabrice Roegiers

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in cell biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Biological Significance of NOTCH Signaling Strength.Frontiers in cell and developmental biology · 2021
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vasundhara KandacharProgram in Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA 19111, United States.
Fabrice Roegiers
Fox Chase Cancer Center · US

Funding

Endocytic Control of Notch-Mediated Cell Fate Decisions in NeurogenesisR01NS059971 · NINDS · RESEARCH INST OF FOX CHASE CAN CTR · PI ROEGIERS, FABRICE J. · 2008 to 2012
$1.7M
NINDS NIH HHS R01 NS059971
6 · The paper itself

Abstract

The Notch signaling pathway controls patterning and cell fate decisions during development in metazoans, and is associated with human diseases such as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and certain cancers. Studies over the last several years have revealed sophisticated regulation of both the membrane-bound Notch receptor and its ligands by vesicle trafficking. This is perhaps most evident in neural progenitor cells in Drosophila, which divide asymmetrically to segregate Numb, an endocytic adaptor protein that acts as a Notch pathway inhibitor, to one daughter cell. Here, we discuss recent findings addressing how receptor and ligand trafficking to specific membrane compartments control activation of the Notch pathway in asymmetrically dividing cells and other tissues.

Indexed as

EndocytosisSignal TransductionAnimalsAsymmetric Cell DivisionDrosophila melanogasterDrosophila ProteinsHumansJuvenile HormonesLigandsNeural Stem CellsProtein TransportReceptors, NotchDrosophila ProteinsJuvenile HormonesLigandsnumb protein, DrosophilaReceptors, Notch

Identifiers

PMID22818956
PMCPMC3425709
OpenAlexW2162066500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.